{
    "code": "02025272",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025272",
    "time": "2024-03-21 19:29:52",
    "許可證字號": "衛署藥輸字第025272號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/10\/05",
    "發證\/登錄日期": "99\/10\/05",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202527201",
    "中文品名": "返利凝25毫克膜衣錠",
    "英文品名": "Revolade film-coated tablets 25mg",
    "適應症": "1. 用於對於其他治療 (例如:類固醇、免疫球蛋白等)失敗之免疫性血小板減少症 (immune thrombocytopenia; ITP) 成年病人。\r\n2. 用於對於其他治療(例如:類固醇、免疫球蛋白等)失敗且診斷後持續六個月以上之6歲至17歲免疫性血小板減少症 (immune thrombocytopenia; ITP)病人。\r\n3. 用於慢性C型肝炎病毒 (HCV) 感染的成年病人，治療其因血小板減少症而無法順利展開及持續干擾素治療 。\r\n4. 與標準免疫抑制療法併用，用於成年及12歲(含)以上嚴重再生不良性貧血(SAA)病人的第一線療法。\r\n5. 適用在對於免疫抑制療法反應不佳的嚴重再生不良性貧血(SAA)病人。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠以下鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ELTROMBOPAG OLAMINE, MILLED",
    "限制項目": "02輸　入",
    "申請商名稱": "台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "Novartis Pharmaceutical Manufacturing LLC",
            "製造廠廠址": "Verovskova ulica 57 1000 Ljubljana Slovenia",
            "製造廠公司地址": "",
            "製造廠國別": "SLOVENIA",
            "製程": "製造、包裝"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200090610",
            "成分名稱": "ELTROMBOPAG OLAMINE, MILLED",
            "含量描述": "",
            "含量": "31.9000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "025272_Revolade film-coated tablets 25mg-108-06-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025272&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "返利凝25毫克膜衣錠仿單-111-08-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025272&Seq=020&Type=9"
        },
        {
            "title": "Revolade_TWL-181019 (new office address)-108-10-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025272&Seq=008&Type=8"
        },
        {
            "title": "025272_Revolade film-coated tablets 25mg-108-06-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025272&Seq=007&Type=8"
        },
        {
            "title": "020252720001-105-03-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025272&Seq=006&Type=8"
        }
    ]
}